Recognizing Remission in Lupus
October 30, 2018
Researchers are trying to ascertain the important issue in SLE of how much improvement in disease activity...
Search Results
You searched for: Research Portfolio
Results found: 856
Researchers Make Strides in Predicting COVID-19 Response, New LRA Study Finds
October 15, 2020
Some people respond to COVID-19 by releasing high amounts of immune proteins called cytokines, which form when...
An IDEAL Initiative in Lupus Research: Q&A With Dr. Stacie Bell, Lupus Therapeutics, and Dr. Teodora Staeva, Lupus Research Alliance
Could diet and gut health impact the lived experience of lupus? This intriguing question lies at the heart of...
2024 Lupus Research Alliance Gala Raises Millions to Improve Lives of People with Lupus
Star-studded evening featured Tamron Hall, Halsey, and Honored LRA Founder Robert Wood Johnson and Verizon Chairman and CEO Hans Vestberg...
LRA-Funded Discovery May Improve Effectiveness of Vaccines and Autoimmune Treatments
August 5, 2021
Researchers at St. Jude Children’s Research Hospital identified the series of molecules that guide a sub-set of...
Exercise Improves Ability to Function for People with Lupus Shows Study
January 31, 2020
A new study published in Rheumatic & Musculoskeletal Diseases showed that exercising the upper extremities – shoulder,...
Our Impact
April 2023
As the largest private funder of lupus research in the world, the Lupus Research Alliance (LRA) is leading...
Impact of Clinical Research
Clinical trials are an important step in discovering new treatments for lupus and other diseases, as well as new...
Lupus Research Alliance Grants $6 Million in First Global Team Science Awards
This Largest-Ever Grant Will Fund Two Projects Examining Why Lupus Differs for Each Person
NEW YORK, NY. Sept. 21, 2021....
Lupus Therapeutics Statement on Positive Data from Phase 3 PHOENYCS GO Trial in Moderate-To-Severe Systemic Lupus
Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance (LRA), is encouraged by the positive Phase 3...
Positive Study Results in Potential Treatment for Cutaneous and Systemic Lupus
December 3, 2019
The Lupus Research Alliance (LRA) is pleased to share positive results reported by Biogen Inc. from the...
New Phase 3 Study Shows Positive Results for Benlysta® in Lupus Nephritis
December 17, 2019
The Lupus Research Alliance is thrilled to share exciting news from GSK that Benlysta (belimumab) demonstrated positive...